Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.

Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, Misore A, Otieno J, Jamieson D, Thigpen MC, Bulterys M, Slutsker L, De Cock KM, Amornkul PN, Greenberg AE, Fowler MG; KiBS Study Team.

PLoS Med. 2011 Mar;8(3):e1001015. doi: 10.1371/journal.pmed.1001015. Epub 2011 Mar 29.

2.

Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.

Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, Odhiambo P, Fowler MG, Weidle PJ, Thigpen MC.

Antimicrob Agents Chemother. 2009 Mar;53(3):1170-6. doi: 10.1128/AAC.01117-08. Epub 2008 Dec 29.

3.

Early antiretroviral therapy and mortality among HIV-infected infants.

Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA; CHER Study Team.

N Engl J Med. 2008 Nov 20;359(21):2233-44. doi: 10.1056/NEJMoa0800971.

4.

Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.

Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, Musoke P, Mmiro F, Jackson JB, Eshleman SH.

J Infect Dis. 2008 Oct 1;198(7):1075-82. doi: 10.1086/591503.

5.

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE.

N Engl J Med. 2008 Jul 10;359(2):119-29. doi: 10.1056/NEJMoa0801941. Epub 2008 Jun 4.

6.

18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.

Harambat J, Fassinou P, Becquet R, Touré P, Rouet F, Dabis F, Msellati P, Blanche S, Timité-Konan M, Salamon R, Leroy V; ANRS 1201/1202 Ditrame Plus Study Group.

BMC Public Health. 2008 May 20;8:169. doi: 10.1186/1471-2458-8-169.

7.

Update of the drug resistance mutations in HIV-1: Spring 2008.

Johnson VA, Brun-Vezinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD.

Top HIV Med. 2008 Apr-May;16(1):62-8. No abstract available. Erratum in: Top HIV Med. 2008 Oct-Nov;16(4):121.

8.

The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk.

Colebunders R, Hodossy B, Burger D, Daems T, Roelens K, Coppens M, Van Bulck B, Jacquemyn Y, Van Wijngaerden E, Fransen K.

AIDS. 2005 Nov 4;19(16):1912-5.

PMID:
16227801
9.

Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya.

Yang C, Li M, Shi YP, Winter J, van Eijk AM, Ayisi J, Hu DJ, Steketee R, Nahlen BL, Lal RB.

AIDS Res Hum Retroviruses. 2004 May;20(5):565-74.

PMID:
15186532
10.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.

Lancet. 2003 Sep 13;362(9387):859-68.

PMID:
13678973
11.

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators.

J Infect Dis. 2003 Mar 1;187(5):725-35. Epub 2003 Feb 24.

12.

Breastfeeding decisions.

Heinig MJ.

Pediatrics. 2002 Nov;110(5):1033-4; author reply 1033-4. No abstract available.

PMID:
12415055
13.

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL; International PACTG 316 Team.

JAMA. 2002 Jul 10;288(2):189-98.

PMID:
12095383
14.

HIV-1/AIDS and maternal and child health in Africa.

Dabis F, Ekpini ER.

Lancet. 2002 Jun 15;359(9323):2097-104. Review.

PMID:
12086778
15.

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.

Mirochnick M, Siminski S, Fenton T, Lugo M, Sullivan JL.

Pediatr Infect Dis J. 2001 Aug;20(8):803-5.

PMID:
11734746
16.

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB.

AIDS. 2001 Oct 19;15(15):1951-7.

PMID:
11600822
17.

Host defense benefits of breastfeeding for the infant. Effect of breastfeeding duration and exclusivity.

Heinig MJ.

Pediatr Clin North Am. 2001 Feb;48(1):105-23, ix. Review.

PMID:
11236719
18.

Advances and research directions in the prevention of mother-to-child HIV-1 transmission.

Mofenson LM, McIntyre JA.

Lancet. 2000 Jun 24;355(9222):2237-44. Review.

PMID:
10881908
19.

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE.

Lancet. 1999 Mar 6;353(9155):781-5.

PMID:
10459958
20.

The American Academy of Pediatrics recommendations on breastfeeding and the use of human milk.

Heinig MJ.

J Hum Lact. 1998 Mar;14(1):2-3. No abstract available.

PMID:
9543949
Items per page

Supplemental Content

Write to the Help Desk